ARTICLE

Volume 11,Issue 4

Cite this article
2
Citations
9
Views
26 April 2026

Study on the Effects of Integrated Traditional Chinese and Western Medicine in Improving Gastroscopic and Pathological Findings in Patients with Chronic Atrophic Gastritis Accompanied by Intestinal Metaplasia

Huanhuan Miao1 Yan Wang1*
Show Less
1 The Affiliated Hospital of Hebei University, Baoding 071000, Hebei, China
APM 2026 , 11(4), 26–33; https://doi.org/10.18063/APM.v11i4.1844
© 2026 by the Author. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Objective: To assess the efficacy of the Integrated Traditional Chinese and Western Medicine (ICWM) program among patients with chronic atrophic gastritis (CAG) associated with intestinal metaplasia (IM) according to their endoscopic morphology and pathological alteration grade. Methods: It was implemented through a randomized controlled trial. There were 100 cases admitted to our hospital from June 2023 to December 2024 who were all suffering from CAG with IM, divided into the observation group (n = 50) and the control group (n = 50), according to the random sequence. Patients in the control group only received traditional Western medicines such as quadruple H. pylori eradication treatment plus mucosa protector. Patients in the observation group had another choice, namely decoctions based on invigorating the spleen and tonifying qi, activating blood circulation and removing blood stasis as well as detoxification according to TCM theories. The treatment period was six months. Efficacy was evaluated according to four aspects, including gastroscopic appearance score, OLGA/OLGIM stage classification of gastric lesion severity degree, serum indicators of PGⅠ, PGR, and G-17 levels, and scores of TCM syndromes. Results: Compared with the control group, all indicators in the observation group had obvious superiority (P < 0.05). Among them, the overall gastroscopic response rate reached 84.0% vs 62.0%; the percentage of OLGA staging regression cases was 72.0% vs 44.0%; the IM improvement rate was 66.0% vs 38.0%; while there were more patients with improvement of TCM syndromes in the observation group (88.0%) than in the control group (64.0%). Conclusion: Integrated Chinese and Western medicine has enhanced efficacy for treating patients with CAG associated with IM.

Keywords
Chronic atrophic gastritis
Intestinal metaplasia
Integrated Chinese and Western medicine
Gastroscopic findings
Histopathology
OLGA staging
Helicobacter pylori
Funding
Project Name: Discussion on Syndrome Differentiation and Treatment Based on "Yiyuan" with the Principle of Drying and Moistening as the Mainline-Clinical Observation of Houpu Xialing Decoction in Treating Chronic Atrophic Gastritis with Severe Intestinal Epithelial Hyperplasia (Project No.: HDFYLL-KY-2024-187)
References

[1] Gao M, Mao Y, 2025, A Case Report of Integrated Traditional Chinese and Western Medicine Treatment for Severe Pneumonia with Pyopneumothorax. Journal of Contemporary Medical Practice, 7(11): 71–75. https://doi.org/10.53469/JCMP.2025.07(11).12

[2] Peng A, Lu Y, 2025, Integrated Traditional Chinese and Western Medicine in the Treatment of Biliary Cholestatic Liver Disease in an Infant with ABCB4 Gene Mutation: A Case Report. Journal of Clinical and Nursing Research, 9(11): 117–125. https://doi.org/10.26689/JCNR.V9I11.11587

[3] Feng P, Du X, 2025, Research Progress on Integrated Traditional Chinese and Western Medicine in the Treatment of Functional Dyspepsia. Journal of Contemporary Medical Practice, 7(9): 64–68. https://doi.org/10.53469/JCMP.2025.07(09).13

[4] Zha R, Zhang S, Wang X, 2025, Research Progress on Integrated Traditional Chinese and Western Medicine Treatment of Rotator Cuff Injuries. Journal of Contemporary Medical Practice, 7(4): 231–234. https://doi.org/10.53469/JCMP.2025.07(04).45

[5] Ma X, Liu Z, Chang T, et al., 2024, Network Meta-Analysis of Integrated Traditional Chinese and Western Medicine in the Treatment of Sjogren’s Syndrome. Frontiers in Pharmacology, 2024: 1455969. https://doi.org/10.3389/FPHAR.2024.1455969

[6] Jia S, Chen Q, Liu X, et al., 2024, Efficacy of Integrated Traditional Chinese and Western Medicine in Managing Mild-Moderate Acute Pancreatitis: A Real-World Clinical Perspective Analysis. Frontiers in Medicine, 2024: 1429546. https://doi.org/10.3389/FMED.2024.1429546

[7] Lang F, Wang M, Tao S, et al., 2024, Research Advancements in the Integrated Traditional Chinese and Western Medicine Approach for the Treatment of Intractable Hiccups after Stroke. Practical Medical Research, 2(7). https://doi.org/10.70711/PMR.V2I7.7721

[8] Jia K, Feng L, Qian LL, 2024, Malignant Proliferating Trichilemmal Tumor Successfully Treated with Integrated Traditional Chinese and Western Medicine: A Case Report. Asian Journal of Surgery, 47(5): 2399–2400. https://doi.org/10.1016/J.ASJSUR.2024.01.053

[9] Research BI, 2023, Retracted: Observation of Curative Effect of Trimetazidine Combined with Metoprolol in Elderly Patients with Coronary Heart Disease Complicated with Heart Failure and the Effect of Myocardial Remodeling by Integrated Traditional Chinese and Western Medicine. BioMed Research International, 2023: 9826080. https://doi.org/10.1155/2023/9826080

[10] Xia W, Zheng C, Zhang J, et al., 2022, Randomized Controlled Study of a Diagnosis and Treatment Plan for Moderate Coronavirus Disease 2019 that Integrates Traditional Chinese and Western Medicine. Journal of Traditional Chinese Medicine, 42(2): 234–241. https://doi.org/10.19852/J.CNKI.JTCM.20210220.001

[11] Qi KS, Tong SL, Ying JL, et al., 2021, Effects of Different Acupuncture Treatment Methods on Post-Stroke Cognitive Impairment: Study Protocol for a Multicenter Randomized Controlled Trial. Trials, 22(1): 27. https://doi.org/10.1186/S13063-020-04959-Y

[12] Zhang Y, Yang Q, Song B, et al., 2024, Efficacy and Safety of Piwei Peiyuan Prescription in the Treatment of Chronic Atrophic Gastritis: A Multicenter, Double-Blind, Double-Simulated, Randomized, Controlled Clinical Trial. Medicine, 103(19): e37981. https://doi.org/10.1097/MD.0000000000037981

[13] Jia Q, Jia Y, Chen Y, et al., 2025, Efficacy and Safety of Traditional Chinese Medicine Elian Granule for Chronic Atrophic Gastritis: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study. Frontiers in Pharmacology, 2025: 1545313. https://doi.org/10.3389/FPHAR.2025.1545313

[14] Luo Y, Xue H, Chen H, et al., 2024, Metabolomics Advances in Chronic Atrophic Gastritis Diagnosis and the Integration of Traditional Chinese Medicine. Saudi Pharmaceutical Journal, 32(12): 102213. https://doi.org/10.1016/J.JSPS.2024.102213

[15] Wang L, Lian JY, Dong SJ, et al., 2025, Traditional Chinese Medicine for Chronic Atrophic Gastritis: Efficacy, Mechanisms and Targets. World Journal of Gastroenterology, 31(9): 102053. https://doi.org/10.3748/WJG.V31.I9.102053

[16] Chang H, Li S, Pan G, et al., 2024, Research Progress of Traditional Chinese Medicine in the Treatment of Chronic Atrophic Gastritis. Journal of Contemporary Medical Practice, 6(4). https://doi.org/10.53469/JCMP.2024.06(04).09

Share
Back to top